Ashland (ASH) SVP Assis Converts RSUs to Shares

What Happened
Assis Alessandra Faccin (SVP and GM, Life Sciences) converted vested restricted stock units into 3,215 shares of Ashland common stock on July 27, 2026. The reported value of those shares at $66.38 each was $213,412. To satisfy tax withholding, 884 shares were surrendered (disposed) at the same price for $58,680, leaving a net 2,331 shares retained (3,215 − 884).

Key Details

• Transaction date: July 27, 2026; Form 4 filed July 29, 2026 (filed on time).
• Conversion: 3,215 RSUs converted to common stock at $66.38 per share (total $213,412).
• Tax withholding: 884 shares withheld/paid for taxes at $66.38 per share (total $58,680).
• Net shares retained after withholding: 2,331 shares (noted by arithmetic; the filing does not separately state post-transaction holdings).
• Relevant footnotes: F2 indicates the tax withholding was done by withholding securities on RSU vesting; F3 notes each RSU equals one share; F4 details the original 2024 RSU grant and vesting schedule. F1 references additional shares/RSUs acquired in lieu of cash dividends.
• Transaction codes: M (exercise/conversion of a derivative instrument) and F (payment of tax liability via withholding securities). A reported line showing 3,215 shares at $0.00 reflects the derivative conversion bookkeeping common on Form 4s.

Context
This was a routine settlement of vested RSUs (not an open-market purchase or sale). Withholding shares to cover taxes is standard and does not necessarily indicate a change in the insider’s view on the stock. The filing was timely (within the usual Form 4 reporting window).